{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T23:15:33Z","timestamp":1649027733281},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[1978,1,1]],"date-time":"1978-01-01T00:00:00Z","timestamp":252460800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Klin Wochenschr"],"published-print":{"date-parts":[[1978,1]]},"DOI":"10.1007\/bf01477460","type":"journal-article","created":{"date-parts":[[2005,4,13]],"date-time":"2005-04-13T23:44:13Z","timestamp":1113435853000},"page":"97-105","source":"Crossref","is-referenced-by-count":2,"title":["Pharmacokinetic and pharmacodynamic studies of infusions with [Sar1, Val5, Ala8] angiotensin II (saralasin)"],"prefix":"10.1007","volume":"56","author":[{"given":"K. H.","family":"Gless","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Gram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"B\ufffdnner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. F. E.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Helber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Ganten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/0002-9343(76)90903-7","volume":"60","author":"D.B. Case","year":"1976","unstructured":"Case, D.B., Wallace, J.M., Keim, H.J., Sealey, J.E., Laragh, J.H.: Usefulness and limitations of saralasin, a partial competitive agonist of angiotensin II, for evaluating the renin and sodium factors in hypertensive patients. Am. J. Med.60, 825?836 (1976a)","journal-title":"Am. J. Med."},{"key":"CR2","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/0002-9343(76)90160-1","volume":"61","author":"D.B. Case","year":"1976","unstructured":"Case, D.B., Wallace, J.M., Keim, H.J., Weber, M.A., Drayer, J.I.M., White, R.P., Sealey, J.E., Laragh, J.H.: Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasin. Am. J. Med.61, 790?796 (1976b)","journal-title":"Am. J. Med."},{"key":"CR3","volume-title":"Radioimmunoassay methods","author":"G. D\u00fcsterdiek","year":"1971","unstructured":"D\u00fcsterdiek, G., McElwee: Iodination of angiotensin II and purification of the labelled hormone. Radioimmunoassay methods. Kirkham, K.E., Hunter, W.M. (eds.). London: Churchill Livingstone, 1971"},{"key":"CR4","first-page":"1136","volume":"I","author":"R. Fagard","year":"1975","unstructured":"Fagard, R., Amery, A., Timmermans, U.: Severe hypotension during infusion of saralasin. LancetI, 1136 (1975)","journal-title":"Lancet"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0140-6736(77)92958-0","volume":"I","author":"R.K. Ferguson","year":"1977","unstructured":"Ferguson, R.K., Turini, G.A., Brunner, H.R., Gavras, H., McKinstry, D.N.: A specific orally active inhibitor of angiotensin-converting enzyme in man. LancetI, 775?778 (1977)","journal-title":"Lancet"},{"key":"CR6","first-page":"455","volume-title":"Methods of Hormone Radioimmunoassay","author":"A.E. Freedlender","year":"1974","unstructured":"Freedlender, A.E., Fyhrquist, F., Hollemans, H.J.G.: Renin and the angiotensins. In: Methods of Hormone Radioimmunoassay. Jaffe, B.E., Behrman, H.R. (eds.) pp. 455?467. New York and London: Academic Press, 1974"},{"key":"CR7","volume-title":"Handbook of Experimental Pharmacology, Vol. 39, Antihypertensive Agents","author":"D. Ganten","year":"1977","unstructured":"Ganten, D., Gross, F.: Handbook of Experimental Pharmacology, Vol. 39, Antihypertensive Agents. F. Gross (ed.). Heidelberg: Springer 1977"},{"key":"CR8","volume-title":"Radioimmunoassay-Renin?Angiotensin. Principles of Radioimmunoassay and their Application in Measuring Renin and Angiotensin","author":"D. Ganten","year":"1978","unstructured":"Ganten, D., Schelling, P., Hoffman, W.E., Phillips, M.I., Ganten, U.: The measurement of extrarenal iso-renins. In: Radioimmunoassay-Renin?Angiotensin. Principles of Radioimmunoassay and their Application in Measuring Renin and Angiotensin. Krause, D., Hummerich, W., Poulsen, K. (eds.). Stuttgart: Thieme 1978"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1056\/NEJM197410172911603","volume":"291","author":"H. Gavras","year":"1974","unstructured":"Gavras, H., Brunner, H.R., Laragh, J.H., Sealey, J.E., Gavras, I., Vukovich, R.A.: An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. N. Engl. J. Med.291, 817?821 (1974)","journal-title":"N. Engl. J. Med."},{"key":"CR10","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(76)92222-4","volume":"I","author":"G.G. Geyskees","year":"1976","unstructured":"Geyskees, G.G., Boer, P., Vos, J., Dorhout Mess, E.J.: Renin dependency of blood pressure. Analysis by angiotensin II antagonist P 113 in hypertensive patients treated with salt depletion and propranolol. LancetI, 1049?1051 (1976)","journal-title":"Lancet"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1042\/bj0890114","volume":"89","author":"F.C. Greenwood","year":"1963","unstructured":"Greenwood, F.C., Hunter, W.M., Glover, J.S.: The preparation of131I-labelled human growth hormone of high specific activity. Biochem. J.89, 114?123 (1963)","journal-title":"Biochem. J."},{"key":"CR12","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJM197611182952106","volume":"295","author":"H.J. Keim","year":"1976","unstructured":"Keim, H.J., Drayer, J.I., Case, D.B., Lopez-Ovejero, J., Wallace, J.M., Weber, M.A., Laragh, J.H.: A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate. N. Engl. J. Med.295, 1175?1177 (1976)","journal-title":"N. Engl. J. Med."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(75)90088-4","volume":"I","author":"G.A. MacGregor","year":"1975","unstructured":"MacGregor, G.A.: Hypotension during angiotensin blockade with saralasin. LancetI, 181?182 (1975)","journal-title":"Lancet"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2125.1976.tb00625.x","volume":"3","author":"G.A. MacGregor","year":"1976","unstructured":"MacGregor, G.A., Dawes, P.M.: Agonist and antagonist effects of sar1-ala8-angiotensin II in salt-loaded and salt-depleted normal man. J. Clin. Pharmacol.3, 483?487 (1976)","journal-title":"J. Clin. Pharmacol."},{"key":"CR15","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1464-410X.1977.tb04099.x","volume":"49","author":"L.S. Marks","year":"1977","unstructured":"Marks, L.S., Maxwell, M.H., Gross, C., Waks, U., Kaufman, J.J.: Angiotensin blockade in renovascular hypertension: A controlled, prospective study. Br. J. Urol.49, 181?188 (1977)","journal-title":"Br. J. Urol."},{"key":"CR16","first-page":"2488","volume":"35","author":"P. Needleman","year":"1976","unstructured":"Needleman, P., Douglas, J.R., Jr., Jokschik, B.A., Blumberg, A.L., Isakson, P.C., Marshal, G.R.: Angiotensin antagonists as pharmacological tools. Fed. Proc.35, 2488?2493 (1976)","journal-title":"Fed. Proc."},{"key":"CR17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jcem-45-1-10","volume":"45","author":"R.H. Noth","year":"1877","unstructured":"Noth, R.H., Tan, S.Y., Mulrow, P.J.: Effects of angiotensin II blockade by saralasin in normal man. J. Clin. Endocr. Metab.45, 10?15 (1877)","journal-title":"J. Clin. Endocr. Metab."},{"key":"CR18","first-page":"146","volume":"17","author":"W.A. Pettinger","year":"1974","unstructured":"Pettinger, W.A., Keeton, K., Tanaka, K.: Radioimmunoassay and pharmacokinetics of saralasin in the rat and hypertensive patients. Clin. Pharmacol.17, 146?158 (1974)","journal-title":"Clin. Pharmacol."},{"key":"CR19","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0140-6736(75)92305-3","volume":"I","author":"W.A. Pettinger","year":"1975","unstructured":"Pettinger, W.A., Keeton, K.: Hypotension during angiotensin blockade with saralasin. LancetI, 1387?1388 (1975)","journal-title":"Lancet"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/BF01482536","volume":"55","author":"A. R\u00f6ckel","year":"1977","unstructured":"R\u00f6ckel, A., Wernze, H., Sabel, B., Heidland, A.: Kritische Analyse des Saralasintestes in der Differenzialdiagnose der Hypertonie. Klin. Wschr.55, 651?656 (1977)","journal-title":"Klin. Wschr."},{"key":"CR21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1161\/01.CIR.53.3.400","volume":"53","author":"J. Sancho","year":"1976","unstructured":"Sancho, J., Re, R., Burton, J., Barger, A.C., Haber, E.: The role of the renin angiotensin aldosterone system in cardiovascular homeostasis in normal human subjects. Circulation53, 400?405 (1976)","journal-title":"Circulation"},{"key":"CR22","volume-title":"Progress in Biochemical Pharmacology","year":"1976","unstructured":"Stokes, G.S., Edwards, K.D.G. (eds.): Drugs affecting the reninangiotensin system. In: Progress in Biochemical Pharmacology. Basel, S. Karger, 1976"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0140-6736(77)92168-7","volume":"I","author":"R.D. Thomas","year":"1977","unstructured":"Thomas, R.D., Ball, S.G., Lee, M.R.: Failure of saralasin to predict a response to surgery in renovascular hypertension. LancetI, 724?726 (1977)","journal-title":"Lancet"}],"container-title":["Klinische Wochenschrift"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01477460.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01477460\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01477460","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T11:32:14Z","timestamp":1556883134000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01477460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1978,1]]},"references-count":23,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[1978,1]]}},"alternative-id":["BF01477460"],"URL":"https:\/\/doi.org\/10.1007\/bf01477460","relation":{},"ISSN":["0023-2173","1432-1440"],"issn-type":[{"value":"0023-2173","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[1978,1]]}}}